Healthcare Capital, LLC v. Healthmed, Inc.

213 F. Supp. 2d 850, 2002 U.S. Dist. LEXIS 19284, 2002 WL 1808238
CourtDistrict Court, S.D. Ohio
DecidedAugust 7, 2002
Docket1:02-cv-00688
StatusPublished
Cited by11 cases

This text of 213 F. Supp. 2d 850 (Healthcare Capital, LLC v. Healthmed, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Healthcare Capital, LLC v. Healthmed, Inc., 213 F. Supp. 2d 850, 2002 U.S. Dist. LEXIS 19284, 2002 WL 1808238 (S.D. Ohio 2002).

Opinion

OPINION AND ORDER

MARBLEY, District Judge.

I. INTRODUCTION

This matter is before the Court on the Defendants’ Motion to Dismiss on Jurisdictional Grounds Only, filed on July 24, 2002. On that same date, the Plaintiff filed a Memorandum in Support of Jurisdiction. Subsequently, the Defendants filed a Memorandum in Opposition to the Plaintiffs Memorandum in Support of Jurisdiction, and the Plaintiff filed a Response to Defendants’ Motion to Dismiss. The jurisdictional issue has been placed on an expedited briefing schedule due to the Plaintiffs pending motion for a preliminary injunction, currently set for hearing on September 3, 2002.

For the following reasons, the Court GRANTS the Defendants’ Motion to Dismiss.

II. BACKGROUND

A. Facts

The Plaintiff, Healthcare Capital, LLC (“HCC”), is a Nevada limited liability company with its principal place of business in Franklin County, Ohio. Defendant HealthMed, Inc. (“HealthMed”) is a Nevada corporation with its principal place of business in Los Angeles County, California. Defendant Mitchell Stein (“Stein”), a California resident, is an officer and director of HealthMed, as well as the majority shareholder of HealthMed. Emanual Barling, Jr. (“Barling”), a California resident, is the Chief Executive Officer of HealthMed. The Plaintiff alleges that *852 Barling’s interests are so aligned with Stein’s interests that he constitutes an agent or representative of Stein in his dealings with HealthMed and other institutions. Defendant Swab Financial, RLC, fka TSI Technologies and Holdings, LLC (“Swab”), is a California limited liability company with its principal place of business in Los Angeles County, California. At all times relevant, HealthMed was the sole member of Swab. Swab has owned shares of stock in Med Diversified, Inc. (“Med Diversified”), a publicly traded company, among its other assets.

1. HCC’s Allegations

HCC asserts that it currently owns 667 shares of preferred stock of HealthMed, and that it has held those shares continuously since 1998. HCC also claims that all of the remaining shares in HealthMed are held by entities that are controlled by Stein or his wife, Tracy Hampton. HCC further contends that it is a minority shareholder in Med Diversified. HCC claims that in early 1999, Swab and Stein, or entities controlled by Stein, were the majority shareholders of Med Diversified.

According to HCC, Stein and Barling, on behalf of themselves and on behalf of HealthMed and Swab, directed letters, facsimiles, and telephone calls to HCC in Ohio in an attempt to solicit HCC’s participation in a business association with the Defendants. HCC also claims that Stein visited Ohio in pursuit of a business relationship with HCC at least three times. As a result of their negotiations, HCC and HealthMed entered into an agreement known as the Alliance and Release Agreement (“Agreement”) in January 1998. According to Donald Ayers, a member of HCC, the purpose of the Agreement, which he says was executed in Ohio, was to establish a joint venture between HCC and HealthMed.

HCC contends, on information and belief, that, as the sole member of Swab, HealthMed, through Stein and Barling, caused Swab to transfer substantial assets in the form of common stock of Med Diversified to San Diego Asset Management without notice to, or approval of, Heathmed’s shareholders, including HCC. HCC alleges that Stein, Barling, and Swab transferred such stock and received payment for the sale in an effort to: (1) convert the proceeds, and then hide those proceeds from HCC; and (2) to conceal the sale of the stock from HCC, the Internal Revenue Service, and federal and state regulatory authorities. According to HCC, San Diego Asset Management defaulted on the payment for the sale of the Med Diversified stock. Swab, through Stein and Barling, filed a lawsuit against San Diego Asset Management to recover the purchase price, but then dismissed the lawsuit without obtaining payment of the full purchase price of the stock.

HCC also alleges that Stein and Barling engaged in a number of improper and illegal securities activities pertaining to the Med Diversified stock. In particular, HCC contends that Stein and Barling engaged in what they refer to as a “pump and dump” scheme, 1 conducted insider trading, and filed misleading and fraudulent reports with the Securities and Exchange Commission (“SEC”). HCC states that such actions exposed HealthMed and Swab to the risk of securities law liabilities. HCC adds that the Defendants un *853 dertook these improper activities for their own personal gain, and in direct opposition to the legitimate interests of HCC as a minority shareholder of HealthMed. HCC claims that, unaware of such improper conduct, it opted to retain its stock with the consequence that its holdings became worthless because of the Defendants’ actions.

Finally, HCC alleges that Stein and Barling converted HealthMed’s and Swab’s assets to pay for personal expenses. HCC contends that the Defendants transferred or deposited HealthMed and Swab assets to various persons and entities for the purpose of paying for personal expenses, and for the purpose of fraudulently conveying or hiding assets and funds belonging to the Plaintiff. In addition, HCC claims that Stein transferred HealthMed and Swab assets to offshore bank and brokerage accounts and/or entities controlled by Stein, for the purpose of concealing, hiding, and withholding the transfers and assets from HCC and HealthMed’s and Swab’s other shareholders.

2. Defendants’ Allegations

In response to all of HCC’s allegations, the Defendants contend that HCC no longer owns HealthMed preferred stock, and, therefore, has no basis upon which to challenge any of the Defendants’ actions with respect to that stock. HealthMed contends that it redeemed HCC’s stock for $50,000 in January 2000, and that HCC has not owned stock in HealthMed since that time. 2 HCC does not deny receiving payment from HealthMed for $50,000, but claims that the payment was for accrued interest owed on a $750,000 loan made to HealthMed in March 1999, not for redemption of the stock.

B. Procedural Background

On May 10, 2002, National Century Financial Enterprises, Inc. (“NCFE”) filed a complaint with this Court (Judge Hol-schuh) against Swab, TSI Technologies and Holdings Ltd., LLC, and Barling (“NCFE Litigation”). 3 NCFE is owned by Donald Ayers, Rebecca Parrett, Lance Poulsen, and Barbara Poulsen, who also own HCC. The NCFE Litigation relates to a dispute arising from an agreement entered into between NCFE and Med Diversified pursuant to which Med Diversified was to have developed and maintained specialized software for use by NCFE in exchange for consideration that was to be provided by NCFE.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
213 F. Supp. 2d 850, 2002 U.S. Dist. LEXIS 19284, 2002 WL 1808238, Counsel Stack Legal Research, https://law.counselstack.com/opinion/healthcare-capital-llc-v-healthmed-inc-ohsd-2002.